| Line 135: | Line 135: | ||
*In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. | *In conclusion, smokers who quit by switching to regular ECs use can reduce risk and reverse harm from tobacco smoking. | ||
*Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. | *Innovation in the e-vapour category is likely not only to further minimise residual health risks, but also to maximise health benefits. | ||
===2015: [https://www.discoverymedicine.com/Riccardo-Polosa/2015/09/what-to-advise-to-respiratory-patients-intending-to-use-electronic-cigarettes/ What to Advise to Respiratory Patients Intending to Use Electronic Cigarettes]=== | |||
*The notion that under normal vaping conditions, EC toxicology is by far less problematic than tobacco cigarette toxicology and that there are beneficial effects associated with regular EC use, particularly in respiratory patients, will improve information exchange between physicians and their respiratory patients using or intending to use ECs. | |||
*Therefore, smoking cessation should be strongly encouraged in respiratory patients who smoke, and they should be offered effective personalized strategies. Besides pharmacotherapy and behavioral support, other options should be made available to manage smokers who frequently relapse, and for those who are unable or unwilling to quit. A realistic alternative is to encourage these smokers to switch to ECs, a much less harmful source of nicotine | |||
===2014: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053879/ Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal]=== | ===2014: [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053879/ Effect of Smoking Abstinence and Reduction in Asthmatic Smokers Switching to Electronic Cigarettes: Evidence for Harm Reversal]=== | ||
edits